Role of tau protein in both physiological and pathological conditions
- PMID: 15044677
- DOI: 10.1152/physrev.00024.2003
Role of tau protein in both physiological and pathological conditions
Abstract
The morphology of a neuron is determined by its cytoskeletal scaffolding. Thus proteins that associate with the principal cytoskeletal components such as the microtubules have a strong influence on both the morphology and physiology of neurons. Tau is a microtubule-associated protein that stabilizes neuronal microtubules under normal physiological conditions. However, in certain pathological situations, tau protein may undergo modifications, mainly through phosphorylation, that can result in the generation of aberrant aggregates that are toxic to neurons. This process occurs in a number of neurological disorders collectively known as tauopathies, the most commonly recognized of which is Alzheimer's disease. The purpose of this review is to define the role of tau protein under normal physiological conditions and to highlight the role of the protein in different tauopathies.
Similar articles
-
Microtubule-associated protein tau in development, degeneration and protection of neurons.Prog Neurobiol. 2008 Jun;85(2):148-75. doi: 10.1016/j.pneurobio.2008.03.002. Epub 2008 Mar 22. Prog Neurobiol. 2008. PMID: 18448228 Review.
-
Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.J Neurochem. 2010 May;113(4):895-903. doi: 10.1111/j.1471-4159.2010.06663.x. Epub 2010 Feb 27. J Neurochem. 2010. PMID: 20193038
-
Biochemistry of Tau in Alzheimer's disease and related neurological disorders.Expert Rev Proteomics. 2008 Apr;5(2):207-24. doi: 10.1586/14789450.5.2.207. Expert Rev Proteomics. 2008. PMID: 18466052 Review.
-
[The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].Rev Neurol. 2001 Jul 16-31;33(2):169-77. Rev Neurol. 2001. PMID: 11562878 Review. Spanish.
-
Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.Intern Med J. 2006 Oct;36(10):652-60. doi: 10.1111/j.1445-5994.2006.01153.x. Intern Med J. 2006. PMID: 16958643 Review.
Cited by
-
Advancements in Pharmacological Treatment of Alzheimer's Disease: The Advent of Disease-Modifying Therapies (DMTs).Brain Sci. 2024 Sep 29;14(10):990. doi: 10.3390/brainsci14100990. Brain Sci. 2024. PMID: 39452004 Free PMC article. Review.
-
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder.Neurol Neuroimmunol Neuroinflamm. 2024 Jan;11(1):e200188. doi: 10.1212/NXI.0000000000200188. Epub 2023 Dec 22. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38134369 Free PMC article.
-
Exploring Tau Fibril-Disaggregating and Antioxidating Molecules Binding to Membrane-Bound Amyloid Oligomers Using Machine Learning-Enhanced Docking and Molecular Dynamics.Molecules. 2024 Jun 13;29(12):2818. doi: 10.3390/molecules29122818. Molecules. 2024. PMID: 38930883 Free PMC article.
-
GSK-3 and Tau: A Key Duet in Alzheimer's Disease.Cells. 2021 Mar 24;10(4):721. doi: 10.3390/cells10040721. Cells. 2021. PMID: 33804962 Free PMC article. Review.
-
The ubiquitin proteoform problem.Curr Opin Chem Biol. 2021 Aug;63:95-104. doi: 10.1016/j.cbpa.2021.02.015. Epub 2021 Apr 1. Curr Opin Chem Biol. 2021. PMID: 33813043 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases